X

About this post

Source
Author
Date
4:41 PM | February 13, 2013
Language
English
Categories
URL
Link to this page


The Medical College of Georgia (MSG) announced yesterday, the first FDA-approved, placebo controlled human stem cell clinical trial for Cerebral Palsy (CB). Purpose of the trial is to test the safety and efficacy of autologous stem cells, taken from umbilical cord blood, as a potential treatment for the condition.Full Story

Tags

Comments

Log in to leave a comment